𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of benzophenone-3 after oral exposure in male rats

✍ Scribed by Abdelrazak M. Kadry; Chukwuemeka S. Okereke; Mohamed S. Abdel-Rahman; Marvin A. Friedman; Richard A. Davis


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
518 KB
Volume
15
Category
Article
ISSN
0260-437X

No coin nor oath required. For personal study only.

✦ Synopsis


Benzophenone-3 (BZ-3) is one of the UV-absorbing agents that has been used in industry and medicine for more than 30 years. Millions of consumers are exposed to benzophenones on a daily basis owing to the widespread use of these compounds in many of the products on the market, such as lipsticks, hair sprays, hair dyes, shampoo and detergent bars and sunscreen lotions. This study was performed to investigate the pharmacokinetics of BZ-3 after oral administration at 100 mg kg-' body weight in male Sprague-Dawley rats. Absorption from the gastronintestinal tract was rapid because BZ-3 was detected in blood 5 min after administration. The peak plasma concentration (CmaX) was 25.6 * 4.6 pg ml-' and the time of Occurrence (Lax) was 3.0 ? 0.4 h. The half-life of absorption of BZ-3 was 0.71 h. The elimination pattern was biphasic with a and p half-lives of elimination of 0.88 and 15.90 h, respectively. The results of this study indicate the presence of strong binding between the plasma protein and BZ-3.

Tissue distribution studies at 6 h indicate that the liver contained the highest concentration of free (58.9 +-23.8 wg) and total (free + bound or conjugated) BZ-3 (2087 * 60.1 pg), followed by kidney and testes, respectively. Urine and feces analysis indicate that urine was the major route of excretion, followed by feces. Further analysis of urine samples also indicates that conjugation of BZ-3 with glucuronic acid was the major systemic elimination route for the compound.


πŸ“œ SIMILAR VOLUMES


PHARMACOKINETICS OF SUPEROXIDE DISMUTASE
✍ C. Regnault; M. Soursac; M. Roch-Arveiller; E. Postaire; G. Hazebroucq πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 479 KB πŸ‘ 2 views

The kinetic behaviour of bovine erythrocyte Cu-Zn SOD was investigated in Sprague Dawley male rats after subcutaneous and oral administrations of doses ranging from 0.5 to 20mgkg-I. Studies have been carried out with SOD and SOD encapsulated into liposomes containing or not containing ceramides. The

Pharmacokinetics of Ξ±-mangostin in rats
✍ Li Li; Isabelle Brunner; Ah-Reum Han; Matthias Hamburger; Alan Douglas Kinghorn; πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 171 KB

## Abstract **Scope:** The xanthone α‐mangostin is one of the major bioactive secondary metabolites in __Garcinia mangostana__. Until now, __in vivo__ studies on the absorption, bioavailability, disposition, and metabolism of α‐mangostin are limited. **Methods and results:** In the present study,

Pharmacokinetics of ethopropazine in the
✍ Mojdeh Maboudian-Esfahani; Dion R. Brocks πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

The pharmacokinetics of the anticholinergic drug ethopropazine (ET) have been studied in the rat after intravenous (i.v.) and oral administration. After i.v. doses of 5 and 10 mg/kg ET HCl, mean +/- S.D. plasma AUC were 9836 +/- 2129 (n = 4 rats) and 13096 +/- 4186 ng h/mL (n = 5 rats), respectively

Pharmacokinetics and pharmacodynamics of
✍ Satu M. Somani πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 789 KB

The distribution, metabolism, and pharmacokinetics of physostigmine (Phy) and the time course of butyrylcholinesterase (BuChE) in plasma and cholinesterase (ChE) activity in brain and muscle and their relationship to Phy concentration were described after oral administration of 3H-Phy (650pg kg-') t